A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia

被引：72

作者：

Skeith, Leslie ^{[1
,2
,3
]}

Carrier, Marc ^{[1
,2
,3
,4
]}

Kaaja, Risto ^{[5
,6
]}

Martinelli, Ida ^{[7
]}

Petroff, David ^{[8
]}

Schleussner, Ekkehard ^{[9
]}

Laskin, Carl A. ^{[10
,11
,12
]}

Rodger, Marc A. ^{[1
,2
,3
,4
,13
]}

机构：

[1] Univ Ottawa, Div Hematol, Ottawa Blood Dis Ctr, Ottawa, ON, Canada

[2] Univ Ottawa, Dept Med, Ottawa, ON, Canada

[3] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada

[4] Ottawa Gen Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada

[5] Univ Turku, Dept Med, Turku, Finland

[6] Turku Univ Hosp, FIN-20520 Turku, Finland

[7] Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy

[8] Univ Leipzig, Clin Trial Ctr, D-04109 Leipzig, Germany

[9] Friedrich Schiller Univ Hosp, Dept Obstet & Gynecol, Jena, Germany

[10] LifeQuest Ctr Reprod Med, Toronto, ON, Canada

[11] Univ Toronto, Dept Med, Toronto, ON, Canada

[12] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada

[13] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada

来源：

BLOOD | 2016年 / 127卷 / 13期

关键词：

LOW-DOSE ASPIRIN; RECURRENT MISCARRIAGE; CONSENSUS STATEMENT; FETAL LOSS; MULTICENTER; ASSOCIATION; DEFINITION; ANTIBODIES; DISEASE; TRIAL;

D O I：

10.1182/blood-2015-12-626739

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We performed a meta-analysis of randomized controlled trials comparing low-molecular-weight heparin (LMWH) vs no LMWH in women with inherited thrombophilia and prior late (>= 10 weeks) or recurrent early (<10 weeks) pregnancy loss. Eight trials and 483 patients met our inclusion criteria. There was no significant difference in livebirth rates with the use of LMWH compared with no LMWH (relative risk, 0.81; 95% confidence interval, 0.55-1.19; P = .28), suggesting no benefit of LMWH in preventing recurrent pregnancy loss in women with inherited thrombophilia.

引用

页码：1650 / 1655

页数：6

共 50 条

[41] Hold your needles in women with recurrent pregnancy losses with or without hereditary thrombophilia: Meta-analysis and review of the literature
Intzes, Stergios
Symeonidou, Marianthi
Zagoridis, Konstantinos
Stamou, Maria
Spanoudaki, Athina
Spanoudakis, Emmanouil
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (04)
[42] Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study
Galambosi, Paivi J.
Kaaja, Risto J.
Stefanovic, Vedran
Ulander, Veli-Matti
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (02) : 154 - 159
[43] The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: A systematic review and meta-analysis
Wu, Tingting
Xia, Xiaotong
Chen, Wenjun
Fu, Jinglan
Zhang, Jinhua
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (04) : 602 - 608
[44] Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major orthopedic surgery: a meta-analysis of randomized controlled trials
Zhu, Lemei
Zhu, Bohua
Bing, Pingping
Qi, Mingxu
He, Binsheng
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01):
[45] Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis
Potdar, Neelam
Gelbaya, Tarek A.
Konje, Justin C.
Nardo, Luciano G.
HUMAN REPRODUCTION UPDATE, 2013, 19 (06) : 674 - 684
[46] Low molecular weight heparin for pregnancy complications?
Greer, I. A.
THROMBOSIS RESEARCH, 2009, 123 : S22 - S25
[47] Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
Zhou, Hong
Chen, Ting-Ting
Ye, Ling-ling
Ma, Jun-Jie
Zhang, Jin-Hua
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
[48] Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review
Mantha, S.
Bauer, K. A.
Zwicker, J. I.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (02) : 263 - 268
[49] Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis
Mu, Fangxiang
Wang, Mei
Huang, Jinge
Wang, Fang
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2023, 287 : 29 - 35
[50] COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
Perna, Alessandra F.
Capolongo, Giovanna
Trepiccione, Francesco
Simeoni, Mariadelina
Zacchia, Miriam
Ingrosso, Diego
KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (03): : 357 - 362

← 1 2 3 4 5 →